scispace - formally typeset
R

Rosario Pivonello

Researcher at University of Naples Federico II

Publications -  428
Citations -  18592

Rosario Pivonello is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Acromegaly & Medicine. The author has an hindex of 73, co-authored 352 publications receiving 15514 citations. Previous affiliations of Rosario Pivonello include Erasmus University Rotterdam & University of Genoa.

Papers
More filters
Journal ArticleDOI

Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

Annamaria Colao, +9 more
- 01 Aug 1999 - 
TL;DR: In conclusion, patients with Cushing's disease still have increased cardiovascular risk and suffer from premature atherosclerosis once cured, and patients was probably due to residual abdominal a long term period of WHR, which was inversely correlated to the duration of CD.
Journal ArticleDOI

Complications of Cushing's syndrome: state of the art

Rosario Pivonello, +6 more
- 01 Jul 2016 - 
TL;DR: Cushing's syndrome is a serious endocrine disease caused by chronic, autonomous, and excessive secretion of cortisol, which is associated with increased mortality and impaired quality of life because of the occurrence of comorbidities as discussed by the authors.
Journal ArticleDOI

Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission.

Antongiulio Faggiano, +7 more
- 01 Jun 2003 - 
TL;DR: The persistence of a metabolic syndrome, vascular damage, and atherosclerotic plaques after cortisol level normalization makes patients with Cushing's disease still at high cardiovascular risk despite disease remission, according to this prospective study.
Journal ArticleDOI

The Treatment of Cushing's Disease

Rosario Pivonello, +3 more
- 11 Jun 2015 - 
TL;DR: Recent experience suggests that the combination of different drugs may be able to control cortisol excess in a great majority of patients with Cushing's syndrome.
Journal ArticleDOI

The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery

Rosario Pivonello, +8 more
- 01 Jan 2009 - 
TL;DR: It is demonstrated that cabergoline treatment is effective in controlling cortisol secretion for at least 1-2 yr in more than one third of a limited population of patients with CD.